Viral and nonviral delivery systems for gene delivery
Top Cited Papers
Open Access
- 1 January 2012
- journal article
- review article
- Published by Medknow in Advanced Biomedical Research
- Vol. 1 (1), 27
- https://doi.org/10.4103/2277-9175.98152
Abstract
Gene therapy is the process of introducing foreign genomic materials into host cells to elicit a therapeutic benefit. Although initially the main focus of gene therapy was on special genetic disorders, now diverse diseases with different patterns of inheritance and acquired diseases are targets of gene therapy. There are 2 major categories of gene therapy, including germline gene therapy and somatic gene therapy. Although germline gene therapy may have great potential, because it is currently ethically forbidden, it cannot be used; however, to date human gene therapy has been limited to somatic cells. Although numerous viral and nonviral gene delivery systems have been developed in the last 3 decades, no delivery system has been designed that can be applied in gene therapy of all kinds of cell types in vitro and in vivo with no limitation and side effects. In this review we explain about the history of gene therapy, all types of gene delivery systems for germline (nuclei, egg cells, embryonic stem cells, pronuclear, microinjection, sperm cells) and somatic cells by viral [retroviral, adenoviral, adeno association, helper-dependent adenoviral systems, hybrid adenoviral systems, herpes simplex, pox virus, lentivirus, Epstein-Barr virus)] and nonviral systems (physical: Naked DNA, DNA bombardant, electroporation, hydrodynamic, ultrasound, magnetofection) and (chemical: Cationic lipids, different cationic polymers, lipid polymers). In addition to the above-mentioned, advantages, disadvantages, and practical use of each system are discussed.Keywords
This publication has 110 references indexed in Scilit:
- Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain CancerClinical Cancer Research, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Intravascular adenoviral agents in cancer patients: Lessons from clinical trialsCancer Gene Therapy, 2002
- Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID miceJournal of Hepatology, 2002
- Human Germline Gene Therapy ReconsideredHuman Gene Therapy, 2001
- Use of EBV-Based Vector/HVJ-Liposome Complex Vector for Targeted Gene Therapy of EBV-Associated NeoplasmsBiochemical and Biophysical Research Communications, 1997
- The use of herpes simplex virus-based vectors for gene delivery to the nervous systemMolecular Medicine Today, 1997
- Coupling of cell-binding ligands to polyethylenimine for targeted gene deliveryGene Therapy, 1997
- Gene transfer by electroporationMolecular Biotechnology, 1997
- Peptide-Mediated Gene Delivery: Influence of Peptide Structure on Gene ExpressionBioconjugate Chemistry, 1997